Cricket star's daughter, 21, ‘could have been saved' having visited hospital ‘multiple times', rules inquest
THE daughter of a former England cricketer would not have died if doctors and paramedics had acted faster, a coroner ruled today.
Bethan Amy James, 21 , daughter of ex-England and Glamorgan batsman Steve James, died from sepsis after being sent home from hospital multiple times in the days before her death.
3
Bethan Amy James died aged 21 on February 9, 2020
Credit: Wales News Service
3
Ex-England cricket star Steve James' daughter could have been saved
Credit: Wales News Service
Despite repeated visits to A&E, she was discharged while still seriously unwell.
She collapsed at home on February 8, 2020.
Paramedics were called but delays and a lack of urgency meant she was not treated quickly enough.
By the time she was finally seen in hospital, Bethan was gravely ill and died within hours.
Read more on sepsis
TAKEN TOO SOON Mum, 28, with stomach ache died after hospital staff failed to spot sepsis
Her dad Steve had been in Dublin covering the Six Nations match between Wales and Ireland, but due to weather delays, was unable to get back in time to see her before she passed away.
An inquest heard ambulance crews struggled to insert a line, failed to call for urgent backup, and didn't alert the hospital to her worsening condition.
Bethan was taken to University Hospital Wales in Cardiff, but instead of being rushed into resus, she was taken to the 'majors' unit where medics failed to grasp how sick she was.
Only after a high lactate reading - a sign the body isn't getting enough oxygen and could be shutting down - taken an hour later, did senior doctors intervene.
Senior Coroner Patricia Morgan said: "I find that if earlier recognition and prompt action in response to Bethan's condition by ambulance services had occurred this would have resulted in a pre-alert to the emergency department.
"This would, and ought to have, resulted in direct admission to resus with clinical staff waiting for her."
300,000 people in the UK battle Crohn's Disease, Ulcerative Colitis and other forms of Inflammatory Bowel Disease
She added: "Earlier treatment would and ought to have commenced"
and that "the involvement of other specialists would and ought to have occurred at an earlier stage."
"On balance, I find that had this direct admission to resus and prompt recognition and treatment occurred, then cardiac arrest would not have occurred when it did."
"On balance I find that Bethan would not have died."
A post-mortem found Bethan died from a combination of sepsis, pneumonia and Crohn's disease.
Sepsis is the body's extreme reaction to an infection, where it starts attacking its own organs and tissues, while pneumonia is a severe lung infection.
Crohn's is a lifelong condition whereby parts of the digestive system become inflamed.
She had only recently been diagnosed with Crohn's and had been in and out of hospital in the days leading up to her death.
3
Bethan died from a combination of sepsis, pneumonia and Crohn's disease
Credit: Wales News Service
But sepsis was never picked up.
'Caring' and 'beautiful'
Her mother Jane James told the hearing she felt medics repeatedly missed opportunities to treat her daughter.
She said: "It's heartbreaking as a mum to know that her life could have been saved."
She described Bethan, a journalism student, as a 'caring and beautiful' young woman who would have made a 'brilliant' journalist.
Delivering a narrative conclusion, Ms Morgan said Bethan had visited hospital multiple times between January 27 and February 6 - but was sent home again and again.
Who gets sepsis and what causes it?
Sepsis can affect anyone. The condition occurs when the body's immune system has an overeaction to an infection.
As a result, the body attacks itself.
Some people are more likely to get an infection that could lead to sepsis, however.
This includes babies under the age of one, people over 75 years old, people with diabetes or a weak immune system (either due to treatment, a condition or genetically), people who have recently had surgery or given birth.
Any infection can lead to sepsis. But those more likely to are those of: Lungs, such as pneumonia.
Kidney, bladder and other parts of the urinary system
Digestive system
Bloodstream
Catheter sites
Wounds or burns
She added: "Bethan was reluctant to return [to] hospital due to her lack of confidence arising from earlier attendances.
"When she collapsed at home, her mother called 999. A rapid responder was sent - but wrongly classed the case as non-urgent.
Ms Morgan said: "The rapid responder identified Bethan was in need of admission to hospital and requested a back up ambulance at a non-urgent grade of P3, [but] Bethan's condition warranted an emergency response."
"There was no pre-alert issued to hospital to make them aware of the seriousness of her condition."
"Bethan was transferred to the UHW majors area of the department when she should [have been] admitted directly to resus."
"There was an extended transfer between ambulance and hospital and a delay in recognising Bethan's critical condition once she was admitted."
"This delayed the escalation of her treatment and the input of specialty doctors into her care."
"Bethan sadly went into cardiac arrest and died."
The coroner offered her condolences to Steve and Jane James, who sat through every day of the inquest.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
3 hours ago
- The Independent
Warning over self-swab ‘rape kits' marketed to university students
Self-swab 'rape kits' are being marketed to university students in the UK, allowing individuals to collect and store DNA evidence of an alleged perpetrator. Rape Crisis England and Wales, along with forensic experts, have expressed serious concerns that evidence collected by these kits may not be legally admissible due to contamination risks and lack of comprehensive forensic examination. Critics warn that the kits could give survivors 'false hope' regarding legal outcomes, as professional forensic examinations are conducted in controlled environments and include broader evidence collection. Companies selling the kits, such as 'Enough', claim they act as a deterrent to sexual violence and offer a simpler reporting method, with some students reporting positive perceptions. Beyond legal admissibility, concerns also include the kits' inability to provide the crucial trauma-informed, in-person support that survivors need, which is offered by specialist support services.
The Sun
3 hours ago
- The Sun
Are YOU eligible for free fat jabs on the NHS? As GPs start dishing out Mounjaro – all you need to know
THEY are arguably the biggest medical breakthrough of recent times. And from Monday, so-called ' fat jab s' will be made available to many more Brits on the NHS. In what marks the dawn of a new era, GPs will begin prescribing the weight-loss jab Mounjaro in the first anti- obesity rollout of its kind. More than three million people are thought to be eligible for tirzepatide - the active drug in Mounjaro - the strongest jab on the market. Health chiefs hope it will turn the tide on England's obesity crisis which has seen rates double since the 1990s. Injections including Ozempic and Wegovy have previously only been available for type 2 diabetes or through specialist slimming clinics. Family doctors will now be encouraged to prescribe them in a bid to get more people on the meds. Experts hope widespread use will slash work sick days and boost the economy, while reducing rates of cancer, heart disease and dementia. But demand for the drugs is already huge and NHS clinics cannot dish them out fast enough. Here is everything you need to know as the rollout begins: What is Mounjaro and what has it been used for so far? 5 FOR anyone who has missed the frenzy, Mounjaro, aka tirzepatide, is the newest weight loss injection used on the NHS. It has been around since 2022 and triggers fullness hormones in the gut to prevent hunger and over-eating. This works the same as older jabs Wegovy and Ozempic, all known as GLP-1 agonists, but a recent trial showed it is more effective. A head-to-head study in the New England Journal of Medicine found Mounjaro caused 20 per cent weight loss over 18 months, while semaglutide – the active ingredient in Wegovy and Ozempic – led to 14 per cent. All the jabs were originally invented to treat type 2 diabetes but trials found they could also cause major weight loss. Pharma firms have cashed in on the discovery and UK prescriptions have skyrocketed. NHS prescriptions of Mounjaro in England surged from just 3,300 in 2023 to 1.1million last year, and more than a million people are estimated to be buying it online. Weight Loss Jabs - Pros vs Cons Who will be eligible in the new rollout? THE new rollout starting on Monday will allow GPs to prescribe tirzepatide for weight loss, starting with those patients whose weight places them at greatest health risk. Top of the list will be those with a body mass index (BMI) of 40 or higher and four weight-related health conditions. A BMI of 40 is roughly equal to weighing 16st (102kg) for an average height 5'3' woman, or 19st 6lbs (123kg) for an average 5'9' man. Weight-related conditions include high cholesterol, high blood pressure, prediabetes, type 2 diabetes, obstructive sleep apnoea and heart disease. Patients will likely be expected to have tried diet and exercise first before being offered a jab. Many are likely to miss out, as some 13.5million adults in England are obese but only 3.4million are estimated to be eligible in the rollout. How will the rollout be run and what is new? 5 WHAT'S new is that the rollout will be the first run by NHS primary care, led by GP surgeries. In theory this should make life easier for patients – but GPs will not be able to meet the huge demand. NHS bosses have admitted it will take a staggering 12 years to treat everyone who is eligible. Just 220,000 extra people are likely to get Mounjaro by 2028. Private prescriptions, costing about £100-£150 per month, already vastly outnumber that and are rising. Health Secretary Wes Streeting wants a faster rollout and more widespread use of the drugs but patients must also receive regular check-ups and lifestyle help. Officials are investigating whether they can dish them out through pharmacies or the NHS app to take a load off GPs. Professor Jason Halford, of the European Association for the Study of Obesity, said: 'These drugs have the potential to help millions. 'If the government and NHS are serious about prevention they need to reconsider their position on the speed of the rollout of these drugs.' Professor John Deanfield, a heart doctor at University College London, added: 'These drugs provide a real opportunity to delay many diseases of ageing all at the same time and potentially transform society. 'I hope it won't take 10 years to do something that is so needed.' What if my GP says no? MANY people are expected to miss out and some surgeries are already pouring cold water on patients' hopes. Fairhill Medical Practice in Kingston upon Thames said: 'Once we are able to prescribe weight loss injections they will be offered to those with the highest medical need only, which may mean that a lot of patients will be disappointed.' Millions who meet the prescription criteria will simply have to be denied the drugs because doctors are so busy. On top of everything else England's 6,300 doctors' surgeries have to deal with, they do not have the capacity to offer the necessary long-term supervision for millions more people at once. Experts reckon private prescriptions will rocket even more as frustrated patients give up waiting. If you are eligible but your GP denies you a prescription, you may be able to ask for a referral to specialist weight management services. Known as tier 2 and tier 3 weight management services, they may prescribe the jabs after other weight loss attempts. Many people are expected to find it easier to go private, with the injections widely available from high street pharmacies like Boots, Superdrug, and even Asda. Olivier Picard, of the National Pharmacy Association, said: 'NHS provision won't meet demand straight away, so we fully expect that many people will continue seeking it privately.' Advice for people buying them privately BUYING the drugs online might seem like the faster fix – but buyer beware. Slimming success stories are everywhere but so, too, are tales of horror. Many patients have been duped by dodgy sellers, suffered severe side effects or even died after taking jabs they bought online. Bargain prices, easy tick-box applications, or prescriptions with no follow-up, should all be red flags to online shoppers. Many pharmacies have been rapped for giving them away to people who do not meet the obesity criteria, potentially putting their health at risk. Dose strength is partly based on size and pretending you are fatter than you are could mean you end up with a medication too strong for your body, raising the risk of serious side effects. The most common side effects from the injections include feeling sick, vomiting, diarrhoea or other gut troubles. If not treated properly people can suffer more serious impacts like dehydration, gallstones, pancreatitis or allergic reactions – and more than 100 deaths in the UK have so far been linked to the jabs. The General Pharmaceutical Council issued new rules in February to say that all pharmacies must verify a patient's height and weight, and conduct at least a video call – if not face-to-face appointment – before prescribing weight loss injections. Dr Emily Pegg, associate vice president at Lilly, which makes Mounjaro, said: 'This is still a prescription-only medicine, should only be prescribed by a registered healthcare professional and needs to be dispensed by a registered pharmacy. 'It is not something that people should be able to buy by just going out and going on to a social media site and clicking a button and it gets delivered to them. 'That is not appropriate and is probably illegal. 'Patient safety is a high priority.' Everything you need to know about fat jabs Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases. Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market. Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year. How do they work? The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight. They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists. They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high. Can I get them? NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics. Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure. GPs generally do not prescribe the drugs for weight loss. Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk. Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health. Are there any risks? Yes – side effects are common but most are relatively mild. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health. Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines. Future of fat jabs WHILE the Mounjaro rollout is expected to kick off with a whimper and not a bang, it is hoped it will mark the beginning of a new era in weight loss medicine. Brits have been getting gradually fatter for decades and no medication or government policy has managed to beat the bulge. The drugs appear super-effective, reasonably priced and relatively safe, and could help millions slim down after failed diets. They are expected to reduce the risks of type 2 diabetes, cancer and dementia. And studies increasingly show they improve health in other ways on top of weight loss, too, reducing the risk of heart attacks and strokes. NHS medical director, Professor Sir Stephen Powis, believes they could one day be as transformative as cholesterol-lowering statins, which have slashed heart attacks since they were rolled out decades ago. Prof Powis said: 'I think over time it's highly likely that these drugs will become more widespread. 'I think there will be a combination of increased evidence of positive outcomes and costs dropping, and we will learn better how to deploy them. 'This is very exciting – we're in the foothills of learning how to use them.'
Daily Mail
4 hours ago
- Daily Mail
The 'game-changing' £21 item that sells every two minutes has shoppers floored with incredible results: 'This is brilliant - no more shaving'
MailOnline readers can enjoy an extra 10 per cent off ANSWR's viral Exfoliating Hair Removal Drop, a bestselling alternative to shaving this summer. The Exfoliating Hair Removal Drop is proving to be a hugely popular method for getting rid of unwanted hair, with users saying they'll 'never go back' to shaving their legs. ANSWR Exfoliating Hair Removal Drop The ANSWR Exfoliating Hair Removal Drop is a game-changing hair removal tool, using a glass surface to gently slough away both hair and exfoliate the skin for soft, silky legs and arms. Best used on large areas of skin, the tool also targets dull skin and KP, also known as strawberry skin, for legs that are always holiday-ready. Now 20 per cent off in the brand's sitewide sale, readers can get an additional 10 per cent off with the code discount by using the code SUMMERSKIN10 at checkout. Act fast, as this special offer ends on June 26 2025. £20.81 (save £2.31) Shop Working with a circular rubbing motion on the skin, it promises to remove hair from the surface of the skin while also removing dead skin leaving the skin feeling baby-like. Perhaps best known for their viral At-Home Keratin Treatment, the ANSWR Exfoliating Hair Removal Drop is about to earn its keep in your beauty drawer this summer, too. Currently on sale for 20 per cent off thanks to the brand's storewide Summer sale, MailOnline readers can get an additional 10 per cent off with the code SUMMERSKIN10. The unique device has already converted scores of shoppers from razors and waxing, helping them say goodbye to painful nicks and 'strawberry' legs thanks to the use of friction to help remove hair from the surface of the skin while also removing dead skin. Highly rated by customers, the incredibly easy to use 'drop' has been designed with exfoliation in mind for smooth, soft and silky legs that you won't be able to stop touching. When used in circular motions, the glass surface gently sloughs away both hair and skin for soft, silky legs and arms. When used in circular motions, the glass surface gently sloughs away both hair and skin for soft, silky legs and arms. And while it is a gentler alternative to shaving or waxing it's also proved a winner with those with Keratosis Pilaris (KP), dryness, or strawberry skin, as with regular use it can improve the appearance and softness of the skin. For the best results, the ANSWR Hair Removal Drop should be used on dry skin. Simply buff the drop onto the desired area and you'll be able to watch in awe as hair and dead skin cells fall off in a matter of seconds. Currently on sale for £23.12, MailOnline readers can get an a further 10 per cent off with the code SUMMERSKIN10 taking the cost down to £20.81. Lasting up to six months, it's a cost-effective form of hair removal while also providing a sustainable alternative to traditional razors by replacing an average of 12 razors. 'This is brilliant- no more shaving - instant smooth and feels fabulous. Already recommended to several people. I love it and I'll never go back to shaving my legs again!'. Another agreed, adding: 'My legs are so smooth and no red raised marks anywhere! I braved shorts for the first time in years! Definitely highly recommend. Thank you again for a superb life changing product.' A third penned: 'A fantastic product that leaves legs hair-free and feeling like silk. So much better than shaving or waxing, it's so quick and easy and completely pain free. Love it!'. With one sold every two minutes, it's a great time to see what the hype is about for the hair removing device. Don't miss out on an extra 10 per cent off the ANSWR Exfoliating Hair Removal Drop with the code SUMMERSKIN10.
